From owner-diagnost@hgmp.mrc.ac.uk Tue Aug 8 10:16:36 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id CCC2B17AC2; Tue, 8 Aug 2000 10:16:35 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 60001) id BD2B017B20; Tue, 8 Aug 2000 10:16:34 +0100 (BST) To: diagnost@net.bio.net Newsgroups: bionet.diagnostics From: nobody@hgmp.mrc.ac.uk, [mailto:nobody@hgmp.mrc.ac.uk]@hgmp.mrc.ac.uk, On@hgmp.mrc.ac.uk, Behalf@hgmp.mrc.ac.uk, Of@hgmp.mrc.ac.uk Subject: International Membership Encouraged Message-Id: <20000808091634.BD2B017B20@mercury.hgmp.mrc.ac.uk> Date: Tue, 8 Aug 2000 10:16:34 +0100 (BST) Sender: owner-diagnost@hgmp.mrc.ac.uk Precedence: bulk Dear Sir/Madam, The Society for Molecular and Cell Biology is open for international membership. No geographical exclusivity. Everyone is invited as long as she/he has the minimum requirements. Applications are highly welcomed from new graduates with a Master's Degree in Molecular Biology/ and Cell Biology. For those whose master's are in the related field (Biology, Microbiology etc.) or those who have finished a medical course, they must either have a master's thesis in the area of molecular and cell biology or have undergone considerable training in mol. and cell bio. in a reputable laboratory or have participated in research(es) in the fields of molecular and cell biology from a reputable institution or have taken considerable advanced courses in molecular and cell biology and actively teaching such course(s) in higher education. Letters of recommendation are encouraged from superiors. If interested, kindly send a note to Scientists_2001@yahoo.com Thanks. ____________________________________________ __________________________________________________ Do You Yahoo!? Kick off your party with Yahoo! Invites. http://invites.yahoo.com/ --- From owner-diagnost@hgmp.mrc.ac.uk Thu Aug 10 09:51:34 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id CB6A117AA6; Thu, 10 Aug 2000 09:51:33 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 60001) id 87F7417BCB; Thu, 10 Aug 2000 09:51:32 +0100 (BST) To: diagnost@net.bio.net Newsgroups: bionet.diagnostics From: nobody@hgmp.mrc.ac.uk, [mailto:nobody@hgmp.mrc.ac.uk]@hgmp.mrc.ac.uk, On@hgmp.mrc.ac.uk, Behalf@hgmp.mrc.ac.uk, Of@hgmp.mrc.ac.uk Subject: Great New Cloning Software Message-Id: <20000810085132.87F7417BCB@mercury.hgmp.mrc.ac.uk> Date: Thu, 10 Aug 2000 09:51:32 +0100 (BST) Sender: owner-diagnost@hgmp.mrc.ac.uk Precedence: bulk I have been using a program called Redasoft Plasmid for the past year to aid me in my research. Redasoft recently released a beta version of their new program, Visual Cloning 2000. I thought I would recommend it to you all because I am really impressed by the great graphics and new features. Redasoft has added ORF searching, primer design, a sequence viewer, and more web integration. I've tried Vector NTI and a few others, but found them mostly too expensive and confusing. You can download the beta version of Visual Cloning 2000 at http://www.redasoft.com. Dr. Taylor Robbins --- From owner-diagnost@hgmp.mrc.ac.uk Fri Aug 11 08:43:47 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id 20DB417AD6; Fri, 11 Aug 2000 08:43:47 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 60001) id E640717B02; Fri, 11 Aug 2000 08:43:45 +0100 (BST) To: diagnost@net.bio.net Newsgroups: bionet.diagnostics From: K@hgmp.mrc.ac.uk, HUI@hgmp.mrc.ac.uk, [mailto:huikingfei@hotmail.com]@hgmp.mrc.ac.uk Subject: Looking for faecal occult blood test manufacturer Message-Id: <20000811074345.E640717B02@mercury.hgmp.mrc.ac.uk> Date: Fri, 11 Aug 2000 08:43:45 +0100 (BST) Sender: owner-diagnost@hgmp.mrc.ac.uk Precedence: bulk I am looking for feacal occult blood manufacturer for private label. Contact this writer by e-mail King From owner-diagnost@hgmp.mrc.ac.uk Mon Aug 14 09:43:47 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id CF82317AAD; Mon, 14 Aug 2000 09:43:46 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 60001) id A727817AB0; Mon, 14 Aug 2000 09:43:45 +0100 (BST) To: diagnost@net.bio.net Newsgroups: bionet.diagnostics From: nobody@hgmp.mrc.ac.uk, [mailto:nobody@hgmp.mrc.ac.uk]@hgmp.mrc.ac.uk, On@hgmp.mrc.ac.uk, Behalf@hgmp.mrc.ac.uk, Of@hgmp.mrc.ac.uk Subject: sensi discs Message-Id: <20000814084345.A727817AB0@mercury.hgmp.mrc.ac.uk> Date: Mon, 14 Aug 2000 09:43:45 +0100 (BST) Sender: owner-diagnost@hgmp.mrc.ac.uk Precedence: bulk Hallo I am looking forAntibiotics Sensi-discs for privet label. Thank you Dr. Ury Erez --- From owner-diagnost@hgmp.mrc.ac.uk Mon Aug 21 09:37:09 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id AD72617AE9; Mon, 21 Aug 2000 09:37:08 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 60001) id B656C17AE6; Mon, 21 Aug 2000 09:37:06 +0100 (BST) To: diagnost@net.bio.net Newsgroups: bionet.diagnostics From: nobody@hgmp.mrc.ac.uk, [mailto:nobody@hgmp.mrc.ac.uk]@hgmp.mrc.ac.uk, On@hgmp.mrc.ac.uk, Behalf@hgmp.mrc.ac.uk, Of@hgmp.mrc.ac.uk Subject: Question about the legal use of PCR Message-Id: <20000821083706.B656C17AE6@mercury.hgmp.mrc.ac.uk> Date: Mon, 21 Aug 2000 09:37:06 +0100 (BST) Sender: owner-diagnost@hgmp.mrc.ac.uk Precedence: bulk Can someone tell me if the PCR technique (?? taq-polymerase) can be used in a plant disease diagnostic lab at a university without a liscense? Thanks, Brian --- From owner-diagnost@hgmp.mrc.ac.uk Tue Aug 22 14:14:19 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id 07DC617B3D; Tue, 22 Aug 2000 14:14:18 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 60001) id 474E417B3F; Tue, 22 Aug 2000 14:14:17 +0100 (BST) To: diagnost@net.bio.net Newsgroups: bionet.diagnostics From: news@pale-rider.ins.cwru.edu, [mailto:news@pale-rider.ins.cwru.edu]@hgmp.mrc.ac.uk Subject: Re: Question about the legal use of PCR Message-Id: <20000822131417.474E417B3F@mercury.hgmp.mrc.ac.uk> Date: Tue, 22 Aug 2000 14:14:17 +0100 (BST) Sender: owner-diagnost@hgmp.mrc.ac.uk Precedence: bulk Roche owns most, if not all, of the patents for PCR. Although some of the patents have been in litigation for the past year or two, I believe that Roche is still collecting royalties from those labs that continue to use the technique. When I worked for a clinical lab that was using "homebred" PCR protocols we had to pay a royalty to Roche even though we were not using their kits and reagents.. I'm not a legal authority, and I encourage you to consult one (i.e., if you belong to an academic institution you should talk to your institution's legal counsel), but I would expect that you would have to obtain the license and pay the royalty. nobody@hgmp.mrc.ac.uk, [mailto:nobody@hgmp.mrc.ac.uk], On, Behalf, Of wrote: > Can someone tell me if the PCR technique (?? taq-polymerase) can be > used in a plant disease diagnostic lab at a university without a > liscense? > > Thanks, > Brian > > --- From owner-diagnost@hgmp.mrc.ac.uk Wed Aug 23 15:14:23 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id 0443417AC7; Wed, 23 Aug 2000 15:14:22 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 60001) id 77BE517AA4; Wed, 23 Aug 2000 15:14:21 +0100 (BST) To: diagnost@net.bio.net Newsgroups: bionet.diagnostics From: nobody@hgmp.mrc.ac.uk, [mailto:nobody@hgmp.mrc.ac.uk]@hgmp.mrc.ac.uk, On@hgmp.mrc.ac.uk, Behalf@hgmp.mrc.ac.uk, Of@hgmp.mrc.ac.uk Subject: Conference on Molecular Analysis for Research and Diagnostics Message-Id: <20000823141421.77BE517AA4@mercury.hgmp.mrc.ac.uk> Date: Wed, 23 Aug 2000 15:14:21 +0100 (BST) Sender: owner-diagnost@hgmp.mrc.ac.uk Precedence: bulk First Announcement and Call for Proposals Cambridge Healthtech Institute's Molecular Analysis for Research and Diagnostics February 14-15, 2001 . Hilton San Diego Resort . San Diego, California Following the publication of the draft human genome, even greater emphasis is being placed on innovative techniques and applications for car-rying out molecular analysis of genes and proteins. Improvements in such areas as sample preparation, detection of low copy number prod-ucts, comparison and integration of data on several parameters, including temporal and spatial, are among the techniques that are drawing attention. Whether the purpose of the analysis is better understanding of biology, target identification or validation, or for diagnostics, the role of molecular analysis can be expected to continue to expand rapidly. This conference provides a forum for discussion of key developments and novel solutions that can provide benefits for researchers faced with the challenge of carrying out similar studies. Some of the possible topics to be covered: Sources of material DNA, RNA and proteins . Single cell and in situ Analysis . Tissue libraries . Laser Capture Microdissection Automated sample preparation . Integrated sample prep and analysis Types of analysis Better identification of heterozygote genes . Gene mutations and post-translational modifications Comparisons of gene and protein expression . Temporal and spatial cellular analysis Applications Identifying pathways and response cascades . Molecular characterization of cells and cell lines Validation of molecular targets . Multi-parameter analysis of cellular response to drugs Diagnostic and prognostic biomarkers and patterns To submit a proposal for an oral presentation, please e-mail or fax a proposed presentation title and brief summary (4-5 sentences) by September 8, 2000. Additional supporting material could also be helpful. Poster presentations are also invited. Mary Chitty, Conference Director mchitty@healthtech.com . Fax 617-630-1325 Cambridge Healthtech Institute, 1037 Chestnut Street, Newton Upper Falls MA 02464 USA To be held immediately after CHI's Sixth Quantitative Gene Amplification conference. For exhibit information, please contact Jim MacNeil. Tel: 617-630-1341. Email: jmacneil@healthtech.com For sponsorship information, please contact Al Doig. Tel: 617-630-1312. Email: ardoig@healthtech.com To register on-line, please visit our web site: www.healthtech.com --- From owner-diagnost@hgmp.mrc.ac.uk Thu Aug 24 09:43:56 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id 7BA5F17AD6; Thu, 24 Aug 2000 09:43:55 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 60001) id 5B6CC17AD7; Thu, 24 Aug 2000 09:43:54 +0100 (BST) To: diagnost@net.bio.net Newsgroups: bionet.diagnostics From: news@nic.umass.edu, [mailto:news@nic.umass.edu]@hgmp.mrc.ac.uk, On@hgmp.mrc.ac.uk, Behalf@hgmp.mrc.ac.uk, Of@hgmp.mrc.ac.uk, Ron@hgmp.mrc.ac.uk Subject: RIA/ELISA kit for placental growth hormone Message-Id: <20000824084354.5B6CC17AD7@mercury.hgmp.mrc.ac.uk> Date: Thu, 24 Aug 2000 09:43:54 +0100 (BST) Sender: owner-diagnost@hgmp.mrc.ac.uk Precedence: bulk Humans have two growth hormones, pituitary and placental, that differ in several amino acids. I am searching for a kit to measure levels of placental GH (GH-V). Or, a kit that is specific for only pituitary GH (GH-N). Failing this, is there a vendor for anti-hGH-V antibodies? Ronald Adkins radkins@bio.umass.edu From owner-diagnost@hgmp.mrc.ac.uk Thu Aug 24 09:46:56 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id 59D4F17ADB; Thu, 24 Aug 2000 09:46:55 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 60001) id 3C50317AD8; Thu, 24 Aug 2000 09:46:54 +0100 (BST) To: diagnost@net.bio.net Newsgroups: bionet.diagnostics From: root@library1.airnews.net, [mailto:root@library1.airnews.net]@hgmp.mrc.ac.uk, On@hgmp.mrc.ac.uk Subject: Re: Question about the legal use of PCR Message-Id: <20000824084654.3C50317AD8@mercury.hgmp.mrc.ac.uk> Date: Thu, 24 Aug 2000 09:46:54 +0100 (BST) Sender: owner-diagnost@hgmp.mrc.ac.uk Precedence: bulk Thanks for your reply. I would have expected the royalty would be paid through the purchase of taq, but wasn't sure about the PCR technique. I'm a little surprised that the amplification of dna has a pattent, even in the 'home made' sense!! I'll contact our institution's legal counsel. Thanks Brian On 22 Aug 2000 14:14:15 +0100, news@pale-rider.ins.cwru.edu [mailto:news@pale-rider.ins.cwru.edu] wrote: > >Roche owns most, if not all, of the patents for PCR. Although some of >the >patents have been in litigation for the past year or two, I believe that >Roche >is still collecting royalties from those labs that continue to use the >technique. When I worked for a clinical lab that was using "homebred" >PCR >protocols we had to pay a royalty to Roche even though we were not using >their >kits and reagents.. > >I'm not a legal authority, and I encourage you to consult one (i.e., if >you >belong to an academic institution you should talk to your institution's >legal >counsel), but I would expect that you would have to obtain the license >and pay >the royalty. > >nobody@hgmp.mrc.ac.uk, [mailto:nobody@hgmp.mrc.ac.uk], On, Behalf, Of >wrote: > >> Can someone tell me if the PCR technique (?? taq-polymerase) can be >> used in a plant disease diagnostic lab at a university without a >> liscense? >> >> Thanks, >> Brian >> >> --- > From owner-diagnost@hgmp.mrc.ac.uk Thu Aug 24 09:53:30 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id 7FFB317ADE; Thu, 24 Aug 2000 09:53:29 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 60001) id E362B17ADD; Thu, 24 Aug 2000 09:53:26 +0100 (BST) To: diagnost@net.bio.net Newsgroups: bionet.diagnostics From: owner-diagnost@hgmp.mrc.ac.uk Subject: Re: Question about the legal use of PCR Message-Id: <20000824085326.E362B17ADD@mercury.hgmp.mrc.ac.uk> Date: Thu, 24 Aug 2000 09:53:26 +0100 (BST) Sender: owner-diagnost@hgmp.mrc.ac.uk Precedence: bulk Thanks for your reply. I would have expected the royalty would be paid through the purchase of taq, but wasn't sure about the PCR technique. I'm a little surprised that the amplification of dna has a pattent, even in the 'home made' sense!! I'll contact our institution's legal counsel. Thanks Brian On 22 Aug 2000 14:14:15 +0100, news@pale-rider.ins.cwru.edu [mailto:news@pale-rider.ins.cwru.edu] wrote: > >Roche owns most, if not all, of the patents for PCR. Although some of >the >patents have been in litigation for the past year or two, I believe that >Roche >is still collecting royalties from those labs that continue to use the >technique. When I worked for a clinical lab that was using "homebred" >PCR >protocols we had to pay a royalty to Roche even though we were not using >their >kits and reagents.. > >I'm not a legal authority, and I encourage you to consult one (i.e., if >you >belong to an academic institution you should talk to your institution's >legal >counsel), but I would expect that you would have to obtain the license >and pay >the royalty. > >nobody@hgmp.mrc.ac.uk, [mailto:nobody@hgmp.mrc.ac.uk], On, Behalf, Of >wrote: > >> Can someone tell me if the PCR technique (?? taq-polymerase) can be >> used in a plant disease diagnostic lab at a university without a >> liscense? >> >> Thanks, >> Brian >> >> --- > From owner-diagnost@hgmp.mrc.ac.uk Fri Aug 25 09:28:46 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id 9B28217A61; Fri, 25 Aug 2000 09:28:45 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 60001) id 75DCF17B0C; Fri, 25 Aug 2000 09:28:44 +0100 (BST) To: diagnost@net.bio.net Newsgroups: bionet.diagnostics From: news@eeyore.ins.cwru.edu, [mailto:news@eeyore.ins.cwru.edu]@hgmp.mrc.ac.uk, On@hgmp.mrc.ac.uk Subject: Re: Question about the legal use of PCR Message-Id: <20000825082844.75DCF17B0C@mercury.hgmp.mrc.ac.uk> Date: Fri, 25 Aug 2000 09:28:44 +0100 (BST) Sender: owner-diagnost@hgmp.mrc.ac.uk Precedence: bulk Hello again, I happened to be browsing Roche's USA site and ran across an address where you can get their licensing info. I expect the info to be the same for PCR use in the UK as well as the USA. Here's the quote from one of their web pages: "Further information on purchasing licenses to practice the PCR process may be obtained by contacting the Director of Licensing at the Perkin-Elmer Corporation, 850 Lincoln Center Drive, Foster City, California 94404 or at Roche Molecular Systems, Inc., 1145 Atlantic Avenue, Alameda, California 94501." Good Luck!!! owner-diagnost@hgmp.mrc.ac.uk wrote: > Thanks for your reply. I would have expected the royalty would be > paid through the purchase of taq, but wasn't sure about the PCR > technique. I'm a little surprised that the amplification of dna has a > pattent, even in the 'home made' sense!! > > I'll contact our institution's legal counsel. > > Thanks > Brian > > On 22 Aug 2000 14:14:15 +0100, news@pale-rider.ins.cwru.edu > [mailto:news@pale-rider.ins.cwru.edu] wrote: > > > > >Roche owns most, if not all, of the patents for PCR. Although some of > >the > >patents have been in litigation for the past year or two, I believe that > >Roche > >is still collecting royalties from those labs that continue to use the > >technique. When I worked for a clinical lab that was using "homebred" > >PCR > >protocols we had to pay a royalty to Roche even though we were not using > >their > >kits and reagents.. > > > >I'm not a legal authority, and I encourage you to consult one (i.e., if > >you > >belong to an academic institution you should talk to your institution's > >legal > >counsel), but I would expect that you would have to obtain the license > >and pay > >the royalty. > > > >nobody@hgmp.mrc.ac.uk, [mailto:nobody@hgmp.mrc.ac.uk], On, Behalf, Of > >wrote: > > > >> Can someone tell me if the PCR technique (?? taq-polymerase) can be > >> used in a plant disease diagnostic lab at a university without a > >> liscense? > >> > >> Thanks, > >> Brian > >> > >> --- > > From owner-diagnost@hgmp.mrc.ac.uk Mon Aug 28 08:53:16 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id E360917A9E; Mon, 28 Aug 2000 08:53:15 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 60001) id B2E7117AAC; Mon, 28 Aug 2000 08:53:14 +0100 (BST) To: diagnost@net.bio.net Newsgroups: bionet.diagnostics From: K@hgmp.mrc.ac.uk, HUI@hgmp.mrc.ac.uk, [mailto:huikingfei@hotmail.com]@hgmp.mrc.ac.uk Subject: Re: sensi discs Message-Id: <20000828075314.B2E7117AAC@mercury.hgmp.mrc.ac.uk> Date: Mon, 28 Aug 2000 08:53:14 +0100 (BST) Sender: owner-diagnost@hgmp.mrc.ac.uk Precedence: bulk Would you like them in a vial loose or in a cartridge dispenser. What is the quantity? King wrote in message news:8n8bg0$1cu$1@mercury.hgmp.mrc.ac.uk... > > Hallo > I am looking forAntibiotics Sensi-discs for privet label. > Thank you > Dr. Ury Erez > > > --- > > From owner-diagnost@hgmp.mrc.ac.uk Mon Aug 28 08:53:46 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id B518417A9E; Mon, 28 Aug 2000 08:53:45 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 60001) id A9F1017AB9; Mon, 28 Aug 2000 08:53:44 +0100 (BST) To: diagnost@net.bio.net Newsgroups: bionet.diagnostics From: nobody@hgmp.mrc.ac.uk, [mailto:nobody@hgmp.mrc.ac.uk]@hgmp.mrc.ac.uk, On@hgmp.mrc.ac.uk, Behalf@hgmp.mrc.ac.uk, Of@hgmp.mrc.ac.uk Subject: Re: Question about the legal use of PCR Message-Id: <20000828075344.A9F1017AB9@mercury.hgmp.mrc.ac.uk> Date: Mon, 28 Aug 2000 08:53:44 +0100 (BST) Sender: owner-diagnost@hgmp.mrc.ac.uk Precedence: bulk Cool beans! Thanks for giving me the lead... I found Roche's site and will contact those guys and see what happens (??) Brian On 25 Aug 2000 09:28:43 +0100, news@eeyore.ins.cwru.edu [mailto:news@eeyore.ins.cwru.edu] On wrote: > >Hello again, > > I happened to be browsing Roche's USA site and ran across an address >where you can get their licensing info. I expect the info to be the same >for >PCR use in the UK as well as the USA. Here's the quote from one of their >web >pages: "Further information on purchasing licenses to practice the PCR >process may be obtained by contacting the Director of Licensing at the >Perkin-Elmer Corporation, 850 Lincoln Center Drive, Foster City, >California 94404 or at Roche Molecular Systems, Inc., 1145 Atlantic Avenue, >Alameda, California 94501." > >Good Luck!!! > > >owner-diagnost@hgmp.mrc.ac.uk wrote: > >> Thanks for your reply. I would have expected the royalty would be >> paid through the purchase of taq, but wasn't sure about the PCR >> technique. I'm a little surprised that the amplification of dna has a >> pattent, even in the 'home made' sense!! >> >> I'll contact our institution's legal counsel. >> >> Thanks >> Brian >> >> On 22 Aug 2000 14:14:15 +0100, news@pale-rider.ins.cwru.edu >> [mailto:news@pale-rider.ins.cwru.edu] wrote: >> >> > >> >Roche owns most, if not all, of the patents for PCR. Although some of >> >the >> >patents have been in litigation for the past year or two, I believe that >> >Roche >> >is still collecting royalties from those labs that continue to use the >> >technique. When I worked for a clinical lab that was using "homebred" >> >PCR >> >protocols we had to pay a royalty to Roche even though we were not using >> >their >> >kits and reagents.. >> > >> >I'm not a legal authority, and I encourage you to consult one (i.e., if >> >you >> >belong to an academic institution you should talk to your institution's >> >legal >> >counsel), but I would expect that you would have to obtain the license >> >and pay >> >the royalty. >> > >> >nobody@hgmp.mrc.ac.uk, [mailto:nobody@hgmp.mrc.ac.uk], On, Behalf, Of >> >wrote: >> > >> >> Can someone tell me if the PCR technique (?? taq-polymerase) can be >> >> used in a plant disease diagnostic lab at a university without a >> >> liscense? >> >> >> >> Thanks, >> >> Brian >> >> >> >> --- >> > > ---